Breast Cancer Res Treat
Antineoplastic Combined Chemotherapy ProtocolsNeoplasm MetastasisProtein Kinase Inhibitors
Dr. Hinda Boutrid, MD
NPI1457796070PAC ID4880972397
- Part D claims, 2024
- 1,215
- Publications
- 11
- Hospital affiliations
- 3
- Industry payments
- $40
- Medical groups
- 3
- Practice address
- 300 Pasteur Drive, Stanford, CA 94305
- Practice phone
- Call (650) 723-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Boutrid's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Hinda Boutrid is a hematologist and oncologist in Stanford, California
Dr. Boutrid practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.
Dr. Boutrid's NPI, 1457796070, was assigned on May 9, 2013. Dr. Boutrid graduated from USF Health Morsani College of Medicine in 2013. Dr. Boutrid holds California license A160397.
NPI and contact details
- NPI
- 1457796070NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880972397
- NPI enumeration date
- May 9, 2013
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (650) 723-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 39
- Medical school graduation
- 2013
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Hinda Boutrid practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California
Dr. Boutrid's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.
- Stanford Hospital at 300 Pasteur Drive300 Pasteur Drive, Stanford, CA 94305 · Santa Clara CountyPhone(650) 723-4000
Source: Dmand AI Affiliation Data
Dr. Hinda Boutrid is affiliated with 3 sites of care and 3 medical groups
Dr. Boutrid's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Boutrid is also affiliated with Good Samaritan Hospital. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Boutrid to 1 more hospital and 2 medical groups, each named with a free account. Dr. Boutrid's employer is on file too: a hospital.
Good Samaritan HospitalThe Permanente Medical Group, Inc.1 hospitalName with a free account2 medical groupsNames with a free accountEmployer: hospitalName with a free account
See all 6 affiliations for Dr. BoutridSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Hinda Boutrid's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boutrid practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Stanford Hospital at 300 Pasteur Drive | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Boutrid practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Stanford University and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Hinda Boutrid is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Boutrid's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boutrid is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Boutrid's licenses on file in 2 states: California and Ohio.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Ohio license
Clinical focus
Dmand AI lists colorectal cancer among the conditions Dr. Boutrid treats.
Hematologists and oncologists near Dr. Boutrid
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
1,502hematologists and oncologists in California35hematologists and oncologists in Stanford15hematologists and oncologists at Stanford Hospital at 300 Pasteur Drive
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Hinda Boutrid's patients have a median age of 57
Across all payers, Dmand AI patient panel data puts Dr. Boutrid's median patient age at 57, with 68% women.
Dr. Boutrid's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 57
Patient panel by sex, all payers
- Women68%
- Men31%
Source: Dmand AI Patient Panel Data
Dr. Hinda Boutrid wrote 1,215 Medicare Part D claims in 2024
In 2024, Dr. Boutrid wrote 1,215 Medicare Part D claims for 189 patients. 85% of them were for generic drugs. CMS names the drug for 940 of them, across 27 drugs with 11 or more claims each, at $1,811,532 in total drug cost. In 2023, CMS named 928 claims across 31 drugs.
Part D claims, 20241,215
Drugs named by CMS27
Total drug cost$1.8M
Part D patients189
Dr. Boutrid's Part D claims by kind of drug, 2024
- Generic1,030 claims85%
- Brand-name and other185 claims15%
Dr. Boutrid's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Boutrid's Part D claims, 2024
- Opioids16%194 of 1,215 claims
- Antibiotics1%11 of 1,215 claims
- Antipsychotics, patients 65 and over1%18 of 1,215 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9282024: 9401%
Drugs named by CMS: 27 in 2024, 31 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Hinda Boutrid offers telehealth to Medicare patients
Dr. Boutrid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boutrid as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Boutrid by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Hinda Boutrid has 11 publications on record
Dmand AI links 11 papers to Dr. Boutrid, published from 2008 to 2024. 2008 was the busiest year, with 2. The most frequent topics are Retinal Neoplasms, Retinoblastoma and Carboplatin. Dr. Boutrid has published most often in Invest Ophthalmol Vis Sci. Dr. Boutrid's most frequent co-authors are Timothy G. Murray, MBA, MD, Mohammad Ali Aziz-Sultan, MD and Colleen M. Cebulla, MD.
Papers11
Years published2008 to 2024
Dr. Boutrid's papers by year, 2008 to 2024
Topics Dr. Boutrid writes about most
- Retinal Neoplasms
- Retinoblastoma
- Carboplatin
- Mice, Transgenic
- Antineoplastic Combined Chemotherapy Protocols
- Disease Models, Animal
- Hypoxia
- Microscopy, Fluorescence
Dr. Boutrid's most frequent co-authors
- Timothy G. Murray, MBA, MD8 shared papers
- Mohammad Ali Aziz-Sultan, MD3 shared papers
- Colleen M. Cebulla, MD3 shared papers
Recent publications by Dr. Boutrid
Front Endocrinol (Lausanne)
Breast NeoplasmsCarcinoma, Small CellDNA-Binding Proteins
J Pediatr Ophthalmol Strabismus
Antineoplastic Combined Chemotherapy ProtocolsCarboplatinChemotherapy, Cancer, Regional Perfusion
Invest Ophthalmol Vis Sci
Antineoplastic Combined Chemotherapy ProtocolsCarboplatinDeoxyglucose
See who Dr. Boutrid researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Boutrid works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Hinda Boutrid received $40 in industry payments from 2018 to 2025
CMS Open Payments shows 2 general payments to Dr. Boutrid from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $21.
General payments to Dr. Boutrid by program year, 2018 to 2025
Companies that paid Dr. Boutrid the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Hinda Boutrid graduated from USF Health Morsani College of Medicine
Dr. Boutrid graduated from USF Health Morsani College of Medicine in 2013.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Hinda Boutrid accepts plans from 1 insurance carrier
Dr. Boutrid is in network with 1 carrier, including Aetna. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Aetna
Plan types Dr. Boutrid accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
- PPO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Hinda Boutrid's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Hinda Boutrid
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Hinda Boutrid's NPI number?
Dr. Hinda Boutrid's NPI number is 1457796070. It was assigned on May 9, 2013, and it is active in the NPI Registry.
What kind of doctor is Dr. Hinda Boutrid?
Dr. Hinda Boutrid is a hematologist and oncologist in Stanford, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Hinda Boutrid practice?
Dr. Boutrid practices at 300 Pasteur Drive, Stanford, CA 94305. Dr. Boutrid's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dmand AI also links Dr. Boutrid to 1 hospital and 2 medical groups.
What is Dr. Hinda Boutrid's office phone number?
The practice phone on file for Dr. Boutrid is (650) 723-4000.
What is Dr. Hinda Boutrid's medical license number?
Dr. Boutrid holds California license A160397, one of the licenses on file in 2 states.
Which states has Dr. Hinda Boutrid been licensed in?
Dmand AI has state licenses on file for Dr. Boutrid in California (2019 to 2027) and Ohio (2016 to 2019).
Which hospitals is Dr. Hinda Boutrid affiliated with?
Dr. Boutrid practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California. Dr. Boutrid is also affiliated with Good Samaritan Hospital. Dmand AI links Dr. Boutrid to 1 more hospital.
What medical group is Dr. Hinda Boutrid part of?
Dr. Boutrid is linked to The Permanente Medical Group, Inc. Dmand AI links Dr. Boutrid to 2 more medical groups.
Does Dr. Hinda Boutrid accept Medicare?
Yes. CMS lists Dr. Boutrid as accepting Medicare assignment.
Does Dr. Hinda Boutrid offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Boutrid as offering telehealth services.
Show 8 more questionsShow fewer questions
Is Dr. Hinda Boutrid board certified?
Yes. Dr. Boutrid is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Hinda Boutrid go to medical school?
Dr. Boutrid graduated from USF Health Morsani College of Medicine in 2013.
What drugs does Dr. Hinda Boutrid prescribe most?
In 2024 Medicare Part D data, Dr. Boutrid's most prescribed drugs by claims were Anastrozole, Hydrocodone-Acetaminophen and Ondansetron HCl.
Has Dr. Hinda Boutrid received payments from drug or device companies?
CMS Open Payments shows $40 in general payments to Dr. Boutrid from 2 companies from 2018 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Hinda Boutrid been practicing?
Dr. Boutrid graduated from medical school in 2013, 13 years ago.
Does Dr. Hinda Boutrid do research?
Dmand AI links 11 publications to Dr. Boutrid, published from 2008 to 2024.
Who does Dr. Hinda Boutrid publish with?
Dr. Boutrid's most frequent co-authors are Timothy G. Murray, MBA, MD (8 shared papers), Mohammad Ali Aziz-Sultan, MD (3 shared papers) and Colleen M. Cebulla, MD (3 shared papers).
What insurance does Dr. Hinda Boutrid accept?
Dr. Boutrid is in network with 1 carrier, including Aetna. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card